Paperpal Prime Logo

CNS Neuroscience and Therapeutics : Impact Factor & More

eISSN: 1755-5949pISSN: 1755-5930
JournalOpen Access

Aims and Scope of CNS Neuroscience and Therapeutics

CNS Neuroscience & Therapeutics is a bimonthly medical journal published 1995 by Wiley-Blackwell addressing topics in neurology and central nervous system therapeutic pharmacology. It was established in 1995 as CNS Drug Reviews and obtained its current title in 2008. Less

Key Metrics

CiteScore
8.9
Eigenfactor
0.005 - 0.01
Impact Factor
5 - 10
SJR
Q1Pharmacology
SNIP
1.34
Recommended pre-submission checks
Powered by Paperpal by Editage

Topics Covered on CNS Neuroscience and Therapeutics

CNS Neuroscience and Therapeutics Journal Specifications

Indexed in the following public directories

  • Web of Science Web of Science
  • Scopus Scopus
  • DOAJ DOAJ
  • SJR SJR
Overview
Publisher WILEY
Language English
Frequency Monthly
Article Processing ChargesEUR 2150 | GBP 1900 | USD 2530
Publication Time14
Editorial Review ProcessAnonymous peer review
General Details
LanguageEnglish
FrequencyMonthly
Publication Start Year1995
Publisher URLVisit website
Website URLVisit website
Publication Details
Other chargesVisit website
PlagiarismVisit website
Publication Time 14
Waiver PolicyVisit website
Editorial Review Detail
Editorial TeamVisit website
Review ProcessAnonymous peer review
Review UrlVisit website
Information for authors
Author instructionsVisit website
Copyright DetailsVisit website
Deposit PolicySherpa/Romeo
License typeCC BY
OA statementVisit website
View less

Planning to publish in CNS Neuroscience and Therapeutics ?

Upload your Manuscript to get

  • Degree of match
  • Common matching concepts
  • Additional journal recommendations
Free Report

Recently Published Papers in CNS Neuroscience and Therapeutics

Mapping the Phenotypic Spectrum of Occipital Lobe Epilepsy: A SEEG\u2010Defined Network Classification
  • 7 Aug 2026
  • CNS Neuroscience & Therapeutics
Early Integration of Chinese Medicine Rehabilitation Improves Functional Outcomes in Stroke Patients: A Prospective Pragmatic Study and Nested Case\u2013Control Analysis
  • 7 Aug 2026
  • CNS Neuroscience & Therapeutics
N6\u2010Methyladenosine Demethylase FTO Mitigates Cerebral Ischemia\u2013Reperfusion Injury by Suppressing AQP4 Expression
  • 4 Aug 2026
  • CNS Neuroscience & Therapeutics
An Olfactory Piriform Cortex\u2010Lateral Hypothalamus Neural Circuit Contributes to Linalool\u2010Induced Analgesia
  • 4 Aug 2026
  • CNS Neuroscience & Therapeutics
Geographic Disparities in Stroke Action Awareness in China: A National Survey
  • 4 Aug 2026
  • CNS Neuroscience & Therapeutics
CLRN1 Variants in Müller Cells Cause Mitochondrial Dysfunction in USH3A Retinal Organoids.
  • 1 Aug 2026
  • CNS neuroscience & therapeutics
Mapping the Phenotypic Spectrum of Occipital Lobe Epilepsy: A SEEG\u2010Defined Network Classification
  • 7 Aug 2026
  • CNS Neuroscience & Therapeutics
Early Integration of Chinese Medicine Rehabilitation Improves Functional Outcomes in Stroke Patients: A Prospective Pragmatic Study and Nested Case\u2013Control Analysis
  • 7 Aug 2026
  • CNS Neuroscience & Therapeutics
N6\u2010Methyladenosine Demethylase FTO Mitigates Cerebral Ischemia\u2013Reperfusion Injury by Suppressing AQP4 Expression
  • 4 Aug 2026
  • CNS Neuroscience & Therapeutics
An Olfactory Piriform Cortex\u2010Lateral Hypothalamus Neural Circuit Contributes to Linalool\u2010Induced Analgesia
  • 4 Aug 2026
  • CNS Neuroscience & Therapeutics
Geographic Disparities in Stroke Action Awareness in China: A National Survey
  • 4 Aug 2026
  • CNS Neuroscience & Therapeutics
CLRN1 Variants in Müller Cells Cause Mitochondrial Dysfunction in USH3A Retinal Organoids.
  • 1 Aug 2026
  • CNS neuroscience & therapeutics

FAQs on CNS Neuroscience and Therapeutics